Ledger.Open graph →
SEC Form D · Amendment · filed February 21, 2025

Areteia Therapeutics, Inc

Offering
$445.0M
Sold
$360.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHAPEL HILL, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Paul Berns · Chapel Hill, NCDirectorRobin E. Walker · Chapel Hill, NCExecChristopher E. Courts · Chapel Hill, NCExecJorge E. Bartolome · Chapel Hill, NCExec · DirectorDaniel E. Becker · Chapel Hill, NCDirectorElyse E. Stock · Chapel Hill, NCDirectorBenjamin Gomez · Chapel Hill, NCDirectorIan Read · Chapel Hill, NCDirectorAdam Koppel · Chapel Hill, NCDirectorStephen E. Butts · Chapel Hill, NCDirectorMichael E. Bozik · Chapel Hill, NCDirectorRobin E. Walker · Chapel Hill, NCExecAdam Koppel · Chapel Hill, NCDirectorIan Read · Chapel Hill, NCDirectorDaniel E. Becker · Chapel Hill, NCDirectorJorge E. Bartolome · Chapel Hill, NCExec · DirectorElyse E. Stock · Chapel Hill, NCDirectorChristopher E. Courts · Chapel Hill, NCExecStephen E. Butts · Chapel Hill, NCDirectorBenjamin Gomez · Chapel Hill, NCDirectorMichael E. Bozik · Chapel Hill, NCDirectorPaul Berns · Chapel Hill, NCDirectorMark Kreloff · Denver, COExecJames Brown · Denver, COExecEric Voogt · Denver, CODirectorZach Posner · Denver, CODirectorTommy N. Rogulj · Cremorne, Channel IslandsDirectorJackson N. Zeng · Cremorne, Channel IslandsExec · DirectorLuke Schofield · Cremorne, Channel IslandsDirectorDaniel N. Caruso · Cremorne, Channel IslandsDirectorSusan N. Collas · Cremorne, Channel IslandsDirectorJohn Dorman · Concord, MADirectorMathew Ray · Concord, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗